New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides

Related articles

1. In Vitro Antiviral Activity of the Fungal Metabolite 6-Pentyl-α-Pyrone Against Bovine Coronavirus: A Translational Study to SARS-CoV-2

   This article has 15 authors:

   1. Violetta Iris Vasinioti
   2. Amienwanlen Eugene Odigie
   3. Maria Stella Lucente
   4. Luca Del Sorbo
   5. Cristiana Catella
   6. Elisabetta Casalino
   7. Maria Michela Salvatore
   8. Alessia Staropoli
   9. Francesco Vinale
   10. Maria Tempesta
   11. Filomena Fiorito
   12. Anna Andolfi
   13. Alessio Buonavoglia
   14. Annamaria Pratelli
   15. Paolo Capozza

2. Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor

   This article has 35 authors:

   1. Ed J. Griffen
   2. Daren Fearon
   3. Briana L. McGovern
   4. Lizbe Koekemoer
   5. Blake H. Balcomb
   6. Tamas Szommer
   7. Gwendolyn Fate
   8. Ralph P. Robinson
   9. Bruce A. Lefker
   10. Shirly Duberstein
   11. Noa Lahav
   12. The COVID Moonshot Consortium
   13. Stephanie Braillard
   14. Laura Vangeel
   15. Manon Laporte
   16. Fabienne Burgat Charvillon
   17. A. Kenneth MacLeod
   18. Andrew Wells
   19. Pauline Garner
   20. Richard Knight
   21. Paul Rees
   22. Anthony Simon
   23. Dirk Jochmans
   24. Johan Neyts
   25. Kevin D. Read
   26. Haim Barr
   27. Matthew Robinson
   28. Alpha Lee
   29. Nir London
   30. John Chodera
   31. Frank von Delft
   32. Kris M. White
   33. Ben Perry
   34. Peter Sjö
   35. Annette von Delft

3. Natural flavonoid apigenin and xanthoangelol E are potent antivirals against human metapneumovirus: an in-silico study

   This article has 9 authors:

   1. Hasan Huzayfa Rahaman
   2. Nadim Sharif
   3. Wasifuddin Ahmed
   4. Nazmul Sharif
   5. Rista Majumder
   6. Silvia Aparicio Obregon
   7. Rubén Calderón Iglesias
   8. Isabel Torre Díez
   9. Shuvra Kanti Dey